Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2023 Apr-Jun;24(2):67-92.
doi: 10.4103/heartviews.heartviews_102_22. Epub 2023 Feb 24.

2022 Saudi Guidelines for the Management of Dyslipidemia

Jamilah AlRahimi  1 , Shukri AlSaif  2 , Mirvat Alasnag  3 , Zuhier Awan  4 , Fawaz Almutairi  5 , Hajer Al Mudaiheem  6 , Baris Gencer  7   8 , Alberico L Catapano  9 , François Mach  7 , Adel Tash  10   11
Affiliations

2022 Saudi Guidelines for the Management of Dyslipidemia

Jamilah AlRahimi et al. Heart Views. 2023 Apr-Jun.
No abstract available

PubMed Disclaimer

Conflict of interest statement

There are no conflicts of interest.

Figures

Figure 1
Figure 1
Top 10 causes of DALYs in Saudi Arabia for the periods 1990–2010 and 2010–2017, both sexes. Adapted from Tyrovolas et al.[12] *Percentage change in the number of age-standardized DALYs, 1990–2007, **Percentage change in the number of age-standardized DALYs, 2010–2017. DALYs: Disability-adjusted life-years
Figure 2
Figure 2
Treatment goals across total cardiovascular disease risk categories applied to the Saudi population. Apo-B: Apolipoprotein B, ASCVD: Atherosclerotic cardiovascular disease, BMI: Body mass index, BP: Blood pressure, CKD: Chronic kidney disease, DM: Diabetes mellitus, eGFR: Estimated glomerular filtration rate, FH: Familial hypercholesterolemia, HDL-C: High-density lipoprotein cholesterol, LDL-C: Low-density lipoprotein cholesterol, non-HDL-C: Nonhigh-density lipoprotein cholesterol, SCORE: Systematic Coronary Risk Estimation, T1DM: Type 1 diabetes mellitus, T2DM: Type 2 diabetes mellitus, TC: Total cholesterol
Figure 3
Figure 3
Prevalence of cardiovascular risk factors in Saudi Arabia. *Males. Adapted from Althumiri et al., Alhabib et al., Ahmed et al., Ahmed et al.[784552]
Figure 4
Figure 4
Prevalence of obesity in Saudi Arabia stratified by age group. Adapted from Althumiri et al.[7]
Figure 5
Figure 5
Monitoring statins safety. Note: The risk of myopathy increases in patients with previously high CK, women, elderly, and patients with reduced renal or liver function. CK: Creatine kinase
Figure 6
Figure 6
Comprehensive solutions to encourage the adoption of preventive measures in Saudi Arabia
Figure 7
Figure 7
Clinical pathway (patient journey) of ASCVD patients in Saudi Arabia. *If the nonfasting lipid profile is available with normal levels, no further intervention is needed. ASCVD: Atherosclerotic cardiovascular disease
See this image and copyright information in PMC

References

    1. Aljuaid M, Mannan F, Chaudhry Z, Rawaf S, Majeed A. Quality of care in university hospitals in Saudi Arabia: A systematic review. BMJ Open. 2016;6:e008988. - PMC - PubMed
    1. Almutairi KM, Moussa M. Systematic review of quality of care in Saudi Arabia. A forecast of a high quality health care. Saudi Med J. 2014;35:802–9. - PubMed
    1. Mach F, Baigent C, Catapano AL, Koskinas KC, Casula M, Badimon L, et al. 2019 ESC/EAS Guidelines for the management of dyslipidaemias: Lipid modification to reduce cardiovascular risk. Eur Heart J. 2020;41:111–88. - PubMed
    1. Grundy SM, Stone NJ, Bailey AL, Beam C, Birtcher KK, Blumenthal RS, et al. 2018 AHA/ACC/AACVPR/AAPA/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA Guideline on the management of blood cholesterol: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. Circulation. 2019;139:e1082–143. - PMC - PubMed
    1. Ray KK, Reeskamp LF, Laufs U, Banach M, Mach F, Tokgözoğlu LS, et al. Combination lipid-lowering therapy as first-line strategy in very high-risk patients. Eur Heart J. 2022;43:830–3. - PubMed